Target intelligence / Profile preview

Core histone macro-H2A.2 (MACROH2A2)

Target
MACROH2A2
Molecular classification
Histone variant, Chromatin structural protein
01

Overview

MacroH2A.2 is a member of the histone H2A family encoded by the MACROH2A2 gene (H2AFY2), distinguished by its tripartite structure: a histone fold, an intrinsically disordered linker, and a unique globular macrodomain[4]. It integrates into nucleosomes in place of conventional H2A, reducing transcription and contributing to stable gene silencing, including X chromosome inactivation[2]. MacroH2A variants—including MacroH2A.2—are essential for maintaining higher-order chromatin architecture, stabilizing differentiated cellular states, and suppressing transcriptional noise[3][4]. Unlike its paralog macroH2A1.1, which binds to ADP-ribose and can regulate PARP-1 activity, MacroH2A.2’s macrodomain is incompatible with nucleotide binding and does not directly interact with cellular metabolites[1]. Dysregulation of macroH2A histone variants has context-dependent effects in cancer, often acting as tumor suppressors or barriers to cellular reprogramming[4].

Other names
MacroH2A.2 histoneMACROH2A2H2AFY2Histone macroH2A2mH2A2core histone macro-H2A.2H2A histone family member Y2core histone macroH2A2.2
02

Mechanism of action

Not applicable. No drugs are known to act directly on MacroH2A.2.

03

Biological functions

Chromatin organizationTranscriptional repressionRegulation of gene expressionHeterochromatin stabilizationX chromosome inactivationNuclear architecture maintenance
04

Disease associations

Cancer (involved in tumor suppression and regulation of cellular differentiation)Other (potential roles in benign neoplasms and tissue homeostasis)

Beyond the preview

Go deeper on Core histone macro-H2A.2 (MACROH2A2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Core histone macro-H2A.2 (MACROH2A2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call